<DOC>
	<DOCNO>NCT02155023</DOCNO>
	<brief_summary>Two new glucose sensor ( IR-Glucose Reader ( Joanneum Research , Austria ) , IR-CGM ( IMM , Germany ) ) investigate determine optimal calibration method patient type 1 diabetes</brief_summary>
	<brief_title>Feasibility Study Determine Optimal Calibration Method Glucose Sensors</brief_title>
	<detailed_description>The subject ( Type 1 diabetes ) stay Clinical Research Centre whole period investigation ( 12 hour ) . Continuous blood glucose monitoring perform use IR-Glucose Reader system and/or IR-CGM system base microdialysis . In parallel blood glucose measurement perform every 15 min reference . The measurement sensor calibrate different scheme difference calibrate glucose reading reference blood glucose value determine .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Informed consent obtain advised nature study Male female age 18 75 year ( inclusive ) The subject Type 1 diabetes ( define WHO ) least 24 month Body Mass Index ( BMI ) &lt; = 35 kg/m2 Subject actively enrol another clinical trial take part study within 30 day Experienced recurrent severe hypoglycaemic unawareness ( judged investigator ) A history drug alcohol dependence Positive result HIV antibody Positive result Hepatitis B antigen Hepatitis C antibodies Any significant concomitant disease endocrine , cardiac , neurological , malignant , pancreatic disease uncontrolled hypertension judge investigator Patient pregnant , breast feeding period study Patient donate blood last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>